Protalix (PLX) Affirms Talks, Engages Citigroup as Advisor

February 5, 2013 11:45 AM EST
Protalix BioTherapeutics, Inc. (AMEX: PLX) confirms, in response to inquiries received this morning and a report appearing in the Israeli press, that the company has engaged Citigroup to assist it in reviewing a broad array of product partnering, technology sharing and other strategic alternatives. There is no assurance that Protalix will undertake any such strategic alternative.

Protalix will not comment further on this initiative unless future events would make doing so appropriate.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Mergers and Acquisitions, Rumors, Trader Talk

Related Entities


Add Your Comment